140 related articles for article (PubMed ID: 36863566)
1. Decision-analysis modeling of effectiveness and cost-effectiveness of pharmacologic thromboprophylaxis for surgical inpatients using variable risk assessment models or other strategies.
Davis S; Goodacre S; Horner D; Pandor A; Griffin XL; de Wit K; Hunt BJ; Holland M
J Thromb Haemost; 2023 Jun; 21(6):1580-1591. PubMed ID: 36863566
[TBL] [Abstract][Full Text] [Related]
2. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.
Pandor A; Horner D; Davis S; Goodacre S; Stevens JW; Clowes M; Hunt BJ; Nokes T; Keenan J; de Wit K
Health Technol Assess; 2019 Dec; 23(63):1-190. PubMed ID: 31851608
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study.
Davis S; Goodacre S; Horner D; Pandor A; Holland M; de Wit K; Hunt BJ; Griffin XL
BMJ Med; 2024; 3(1):e000408. PubMed ID: 38389721
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Observational Cohort of Clinical Outcomes in Medical Inpatients prescribed Pharmacological Thromboprophylaxis Using Different Clinical Risk Assessment Models(COMPT RAMs).
Chamoun N; Matta S; Aderian SS; Salibi R; Salameh P; Tayeh G; Haddad E; Ghanem H
Sci Rep; 2019 Dec; 9(1):18366. PubMed ID: 31797897
[TBL] [Abstract][Full Text] [Related]
5. A decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients.
Le P; Martinez KA; Pappas MA; Rothberg MB
J Thromb Haemost; 2017 Jun; 15(6):1132-1141. PubMed ID: 28371250
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa.
Wehmeyer A; Coetzee R; McCartney J
S Afr Med J; 2022 Feb; 112(2):13506. PubMed ID: 35139994
[TBL] [Abstract][Full Text] [Related]
7. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
8. A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting.
Bao Y; Zhao G; Qu S; Xiong T; Yao X; Wu B
Clin Drug Investig; 2020 Feb; 40(2):161-171. PubMed ID: 31773492
[TBL] [Abstract][Full Text] [Related]
9. Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China.
Zhou C; Yi Q; Ge H; Wei H; Liu H; Zhang J; Luo Y; Pan P; Zhang J; Peng L; Aili A; Liu Y; Wang M; Tang Y; Wang L; Zhong X; Wang Y; Zhou H;
Thromb Haemost; 2022 Jul; 122(7):1177-1185. PubMed ID: 34758489
[TBL] [Abstract][Full Text] [Related]
10. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
11. Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT.
Shalhoub J; Lawton R; Hudson J; Baker C; Bradbury A; Dhillon K; Everington T; Gohel MS; Hamady Z; Hunt BJ; Stansby G; Warwick D; Norrie J; Davies AH
Health Technol Assess; 2020 Dec; 24(69):1-80. PubMed ID: 33275096
[TBL] [Abstract][Full Text] [Related]
12. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
[TBL] [Abstract][Full Text] [Related]
13. Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort.
Blondon M; Limacher A; Righini M; Aujesky D; Méan M
Res Pract Thromb Haemost; 2021 Jan; 5(1):142-147. PubMed ID: 33537538
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer.
Kimpton M; Kumar S; Wells PS; Coyle D; Carrier M; Thavorn K
CMAJ; 2021 Oct; 193(40):E1551-E1560. PubMed ID: 35040802
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.
Stuck AK; Spirk D; Schaudt J; Kucher N
Thromb Haemost; 2017 Apr; 117(4):801-808. PubMed ID: 28150851
[TBL] [Abstract][Full Text] [Related]
16. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model.
Zhou H; Hu Y; Li X; Wang L; Wang M; Xiao J; Yi Q
J Atheroscler Thromb; 2018 Nov; 25(11):1091-1104. PubMed ID: 29540637
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Extended Thromboprophylaxis in Patients Undergoing Colorectal Surgery from a Canadian Health Care System Perspective.
Trepanier M; Alhassan N; Sabapathy CA; Liberman AS; Charlebois P; Stein BL; S Feldman L; Lee L
Dis Colon Rectum; 2019 Nov; 62(11):1381-1389. PubMed ID: 31318768
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany.
Schädlich PK; Kentsch M; Weber M; Kämmerer W; Brecht JG; Nadipelli V; Huppertz E
Pharmacoeconomics; 2006; 24(6):571-91. PubMed ID: 16761905
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.
Pandor A; Tonkins M; Goodacre S; Sworn K; Clowes M; Griffin XL; Holland M; Hunt BJ; de Wit K; Horner D
BMJ Open; 2021 Jul; 11(7):e045672. PubMed ID: 34326045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
